More recently, Eikawa et al. demonstrated that metformin exerts an immune-mediated antitumor effect by protect CD8+ tumor-infiltrating lymphocytes (TILs) from apoptosis and inevitable functional exhaustion in the tumor microenvironment, which eventually results in tumor growth inhibition20. Here, CD8A is linked to neoplasm.